Ovid Therapeutics
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Purchase
LEVIN JEREMY M director, officer: CEO
 Common Stock 18,248 $2.76 $50,364
Sale
TARDIO JASON officer: Chief Operating Officer
 Common Stock 17,344 $2.15 $37,290
Option
RAKHIT AMIT officer: President and CMO
 Common Stock 34,017 N/A N/A
Sale
RAKHIT AMIT officer: President and CMO
 Common Stock 34,017 N/A N/A
Option
RAKHIT AMIT officer: President and CMO
 Stock Option (Right to Buy) 34,017 N/A N/A
Purchase
LEVIN JEREMY M director, 10 percent owner, off..
 Common Stock 8,488 N/A N/A
Purchase
LEVIN JEREMY M director, 10 percent owner, off..
 Common Stock 60,000 N/A N/A
Purchase
TAKEDA PHARMACEUTICAL CO LTD 10 percent owner
 Common Stock 2,000,000 N/A N/A
Purchase
BERNSTEIN KAREN director
 Common Stock 10,000 N/A N/A
Purchase
LEVIN JEREMY M director, 10 percent owner, off..
 Common Stock 75,000 N/A N/A
Purchase
WILLIAMS DOUGLAS E director
 Common Stock 5,000 N/A N/A
Purchase
BERNSTEIN KAREN director
 Common Stock 10,000 N/A N/A
Purchase
LEVIN JEREMY M director, 10 percent owner, off..
 Common Stock 15,334 N/A N/A

Showing 1 to 13 of 13 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: